Maximizing Commercial Outcomes for Oncology Medicines

We see what’s possible and bring it to market

Recent News & Events

View All
Secura Bio Announces Two Duvelisib Presentations on Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma at the 2026 American Society of Hematology Annual Meeting Nov 04, 2026 Press Release
Secura Bio Announces Journal of Clinical Oncology Publication of Final Results of Duvelisib PRIMO Phase 2 Trial in Relapsed/Refractory Peripheral T-cell Lymphoma Apr 27, 2026 Press Release
Back to top